Gracell Biotechnologies Initiates Investigational Study Evaluating GC012F for Treatment of Refractory Systemic Lupus Erythematosus (SLE)
Gracell announces start of investigator-initiated trial to expand clinical evaluation of FasTCAR-T GC012F into autoimmune disease GC012F pioneers the use of CD19/BCMA dual-targeting CAR-T in SLE, aiming for deeper and wider depletion of autoantibodies producing B-cells and plasma cells SAN DIEGO, Calif., SUZHOU and SHANGHAI, China, May 15, 2023 /PRNewswire/ -- Gracell...
Hummingbird Bioscience and Merck Enter Collaboration to Evaluate HMBD-001 In Squamous Non-Small Cell Lung Carcinoma
Hummingbird Bioscience enters a clinical trial collaboration and supply agreement with Merck to evaluate HMBD-001, a potentially best-in-class anti-HER3 mAb, in combination with cetuximab, an anti-EGFR mAb, in sqNSCLC HMBD-001 used as monotherapy and in combination with cetuximab has been shown to effectively inhibit tumor growth across various preclinical squamous cell...
Boosting health equity in the world of climate change
Between 2030 and 2050, climate change is expected to cause approximately 250 000 additional deaths per year from malnutrition, malaria, diarrhoea and heat stress alone - WHO Join 200 policy and topic leaders to explore the health risks and impacts of climate change on healthcare SINGAPORE, May 15, 2023 /PRNewswire/ -- Policymakers, health experts, climate experts, business leaders,...
Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
DxI 9000 Access Immunoassay Analyzer Boasts Industry's Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with New Analyte Processing and Detection Technology, Precision Sensors, Smart Algorithms, Remote Real-Time System Monitoring, and is the Only Immunoassay Analyzer with No Daily Maintenancei NT-proBNP Assay Now Available...
Fertility Counts: Merck Launch New Initiative to Underscore the Importance of Sustainable Population Growth in APAC-Region
Fertility Counts seeks to highlight the socio-economic impact of low birth rates on Asia-Pacific (APAC) economies. New Fertility Policy Toolkit, designed by Economist Impact and supported by Merck, proposes evidence-based policy interventions to build more family-friendly societies in APAC. LONDON, May 15, 2023 /PRNewswire/ -- Merck, a leading science and...
TVM Capital Healthcare opens office in Riyadh, Saudi Arabia
DUBAI, UAE and RIYADH, Saudi Arabia, May 15, 2023 /PRNewswire/ -- TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announced today the opening of a new office in the capital of the Kingdom of Saudi Arabia. The purpose of the new office is to advise the group...
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis
SHANGHAI, May 15, 2023 /PRNewswire/ -- Rona Therapeutics, Inc ("Rona") and Keymed Biosciences ("Keymed", HKEX: 02162), today announced a collaboration to jointly discover and develop first-in-class siRNA therapeutics for Glomerulonephritis (also referred as severe kidney diseases). The collaboration will leverage both companies' scientific and technological expertise and will build on Rona's proprietary platform in RNAi targeting liver and extrahepatic...
Zylox-Tonbridge to be Added to MSCI China All Shares Small Cap Index
HANGZHOU, China, May 15, 2023 /PRNewswire/ -- On May 12, MSCI, a leading provider of critical decision support tools and services for the global investment community, announced the results of the May 2023 Index Review for the MSCI Equity Indexes. Zylox-Tonbridge (2190.HK, "the Company") is pleased to learn that the Company's stock will be added to the MSCI China...
Innovent Receives NMPA Breakthrough Designation for IBI351 (KRASG12C Inhibitor) as Monotherapy for Previously Treated Advanced Colorectal Carcinoma
ROCKVILLE, Md. and SUZHOU, China, May 15, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD)...
FDI World Dental Federation’s Virtual Summit ON WORLD ENVIRONMENT DAY TO HIGHLIGHT Sustainable Dental Practices for a Greener Future
GENEVA, May 15, 2023 /PRNewswire/ -- FDI World Dental Federation (FDI) today announces its highly anticipated virtual Summit on Sustainability in Dentistry, taking place on World Environment Day, 5 June. Following the tremendous success of its Sustainability in Dentistry initiative over the past two years, FDI is proud to host this virtual summit as part of the project's second...
